Sheba Medical Center at Tel Hashomer in Tel Aviv signed a historic “Emergency Agreement” with America’s renowned National Institute of Health (NIH) to conduct applied scientific and clinical research in the hunt for treatments that will end the global COVID-19 pandemic.
Sheba Medical Center, which was ranked as one of the Top 10 Hospitals in the World by Newsweek Magazine, will supply the NIH’s Vaccine Research Center with blood samples, plasma and the COVID-19 virus itself from infected patients in Israel, as well as all relevant information via a series of clinical trials the hospital is conducting on various treatments from global pharmaceutical companies, as well as its own experimental treatments.
